Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency

Functional analysis and association with polymorphic haplotypes and two clinical phenotypes

Kaoru Wataya, Jun Akanuma, Patrizia Cavadini, Yoko Aoki, Shigeo Kure, Federica Invernizzi, Ichiro Yoshida, Jun-Ichi Kira, Franco Taroni, Yoichi Matsubara, Kuniaki Narisawa

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Carnitine palmitoyltransferase II (CPT II) deficiency manifests as two different clinical phenotypes: a muscular form and a hepatic form. We have investigated three nonconsanguineous Japanese patients with CPT II deficiency. Molecular analysis revealed two missense mutations, a glutamate (174)to-lysine substitution (E174K) and a phenylalanine (383)-to-tyrosine substitution (F383Y) in the CPT II cDNA. Transfection experiments in COS-1 cells demonstrated that the two mutations markedly decreased the catalytic activity of mutant CPT II. Case 1 (hepatic form) was homozygous for the F383Y mutation, whereas case 3 (muscular form) was homozygous for the E174K mutation. Case 2 and her brother, who were compound heterozygotes for E174K and F383Y, exhibited the hepatic phenotype. We also identified a novel polymorphism in the CPT2 gene, a phenylalanine (352)-tocysteine substitution (F352C), which did not alter CPT II activity in transfected cells. It was present in 21 out of 100 normal alleles in the Japanese population, but absent in Caucasian populations. Genotyping with the F352C polymorphism and the two previously reported polymorphisms, V368I and M647V, allowed normal Japanese alleles to be classified into five haplotypes. In all three families with CPT II deficiency, the E174K mutation resided only on the F1V1M1 allele, whereas the F383Y mutation was observed on the F2V2M1 allele, suggesting a single origin for each mutation.

Original languageEnglish
Pages (from-to)377-386
Number of pages10
JournalHuman mutation
Volume11
Issue number5
DOIs
Publication statusPublished - May 12 1998

Fingerprint

Carnitine O-Palmitoyltransferase
Haplotypes
Phenotype
Mutation
Alleles
Phenylalanine
Liver
COS Cells
Missense Mutation
Heterozygote
Population
Lysine
Transfection
Tyrosine
Siblings
Glutamic Acid
Complementary DNA
Genes

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency : Functional analysis and association with polymorphic haplotypes and two clinical phenotypes. / Wataya, Kaoru; Akanuma, Jun; Cavadini, Patrizia; Aoki, Yoko; Kure, Shigeo; Invernizzi, Federica; Yoshida, Ichiro; Kira, Jun-Ichi; Taroni, Franco; Matsubara, Yoichi; Narisawa, Kuniaki.

In: Human mutation, Vol. 11, No. 5, 12.05.1998, p. 377-386.

Research output: Contribution to journalArticle

Wataya, Kaoru ; Akanuma, Jun ; Cavadini, Patrizia ; Aoki, Yoko ; Kure, Shigeo ; Invernizzi, Federica ; Yoshida, Ichiro ; Kira, Jun-Ichi ; Taroni, Franco ; Matsubara, Yoichi ; Narisawa, Kuniaki. / Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency : Functional analysis and association with polymorphic haplotypes and two clinical phenotypes. In: Human mutation. 1998 ; Vol. 11, No. 5. pp. 377-386.
@article{f5faf90d0bcc417b85a2f7c9f7769e3e,
title = "Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency: Functional analysis and association with polymorphic haplotypes and two clinical phenotypes",
abstract = "Carnitine palmitoyltransferase II (CPT II) deficiency manifests as two different clinical phenotypes: a muscular form and a hepatic form. We have investigated three nonconsanguineous Japanese patients with CPT II deficiency. Molecular analysis revealed two missense mutations, a glutamate (174)to-lysine substitution (E174K) and a phenylalanine (383)-to-tyrosine substitution (F383Y) in the CPT II cDNA. Transfection experiments in COS-1 cells demonstrated that the two mutations markedly decreased the catalytic activity of mutant CPT II. Case 1 (hepatic form) was homozygous for the F383Y mutation, whereas case 3 (muscular form) was homozygous for the E174K mutation. Case 2 and her brother, who were compound heterozygotes for E174K and F383Y, exhibited the hepatic phenotype. We also identified a novel polymorphism in the CPT2 gene, a phenylalanine (352)-tocysteine substitution (F352C), which did not alter CPT II activity in transfected cells. It was present in 21 out of 100 normal alleles in the Japanese population, but absent in Caucasian populations. Genotyping with the F352C polymorphism and the two previously reported polymorphisms, V368I and M647V, allowed normal Japanese alleles to be classified into five haplotypes. In all three families with CPT II deficiency, the E174K mutation resided only on the F1V1M1 allele, whereas the F383Y mutation was observed on the F2V2M1 allele, suggesting a single origin for each mutation.",
author = "Kaoru Wataya and Jun Akanuma and Patrizia Cavadini and Yoko Aoki and Shigeo Kure and Federica Invernizzi and Ichiro Yoshida and Jun-Ichi Kira and Franco Taroni and Yoichi Matsubara and Kuniaki Narisawa",
year = "1998",
month = "5",
day = "12",
doi = "10.1002/(SICI)1098-1004(1998)11:5<377::AID-HUMU5>3.0.CO;2-E",
language = "English",
volume = "11",
pages = "377--386",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency

T2 - Functional analysis and association with polymorphic haplotypes and two clinical phenotypes

AU - Wataya, Kaoru

AU - Akanuma, Jun

AU - Cavadini, Patrizia

AU - Aoki, Yoko

AU - Kure, Shigeo

AU - Invernizzi, Federica

AU - Yoshida, Ichiro

AU - Kira, Jun-Ichi

AU - Taroni, Franco

AU - Matsubara, Yoichi

AU - Narisawa, Kuniaki

PY - 1998/5/12

Y1 - 1998/5/12

N2 - Carnitine palmitoyltransferase II (CPT II) deficiency manifests as two different clinical phenotypes: a muscular form and a hepatic form. We have investigated three nonconsanguineous Japanese patients with CPT II deficiency. Molecular analysis revealed two missense mutations, a glutamate (174)to-lysine substitution (E174K) and a phenylalanine (383)-to-tyrosine substitution (F383Y) in the CPT II cDNA. Transfection experiments in COS-1 cells demonstrated that the two mutations markedly decreased the catalytic activity of mutant CPT II. Case 1 (hepatic form) was homozygous for the F383Y mutation, whereas case 3 (muscular form) was homozygous for the E174K mutation. Case 2 and her brother, who were compound heterozygotes for E174K and F383Y, exhibited the hepatic phenotype. We also identified a novel polymorphism in the CPT2 gene, a phenylalanine (352)-tocysteine substitution (F352C), which did not alter CPT II activity in transfected cells. It was present in 21 out of 100 normal alleles in the Japanese population, but absent in Caucasian populations. Genotyping with the F352C polymorphism and the two previously reported polymorphisms, V368I and M647V, allowed normal Japanese alleles to be classified into five haplotypes. In all three families with CPT II deficiency, the E174K mutation resided only on the F1V1M1 allele, whereas the F383Y mutation was observed on the F2V2M1 allele, suggesting a single origin for each mutation.

AB - Carnitine palmitoyltransferase II (CPT II) deficiency manifests as two different clinical phenotypes: a muscular form and a hepatic form. We have investigated three nonconsanguineous Japanese patients with CPT II deficiency. Molecular analysis revealed two missense mutations, a glutamate (174)to-lysine substitution (E174K) and a phenylalanine (383)-to-tyrosine substitution (F383Y) in the CPT II cDNA. Transfection experiments in COS-1 cells demonstrated that the two mutations markedly decreased the catalytic activity of mutant CPT II. Case 1 (hepatic form) was homozygous for the F383Y mutation, whereas case 3 (muscular form) was homozygous for the E174K mutation. Case 2 and her brother, who were compound heterozygotes for E174K and F383Y, exhibited the hepatic phenotype. We also identified a novel polymorphism in the CPT2 gene, a phenylalanine (352)-tocysteine substitution (F352C), which did not alter CPT II activity in transfected cells. It was present in 21 out of 100 normal alleles in the Japanese population, but absent in Caucasian populations. Genotyping with the F352C polymorphism and the two previously reported polymorphisms, V368I and M647V, allowed normal Japanese alleles to be classified into five haplotypes. In all three families with CPT II deficiency, the E174K mutation resided only on the F1V1M1 allele, whereas the F383Y mutation was observed on the F2V2M1 allele, suggesting a single origin for each mutation.

UR - http://www.scopus.com/inward/record.url?scp=7144227283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7144227283&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-1004(1998)11:5<377::AID-HUMU5>3.0.CO;2-E

DO - 10.1002/(SICI)1098-1004(1998)11:5<377::AID-HUMU5>3.0.CO;2-E

M3 - Article

VL - 11

SP - 377

EP - 386

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 5

ER -